Quality of Life in Patients with Diffuse Lichen Planopilaris: A Cross-Sectional Study of 87 Moroccan Cases

Quality of Life in Patients with Diffuse Lichen Planopilaris: A Cross-Sectional Study of 87 Moroccan Cases

Authors

  • Awatef Kelati Dermatology Department, University Hospital Cheikh Khalifa, and the University Hospital Mohammed VI. Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
  • Marwa Faik Dermatology Department, University Hospital Cheikh Khalifa, and the University Hospital Mohammed VI. Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
  • Soumiya Chiheb Dermatology Department, University Hospital Cheikh Khalifa, and the University Hospital Mohammed VI. Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
  • Madiha El Jazouli Dermatology Department, University Hospital Cheikh Khalifa, and the University Hospital Mohammed VI. Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
  • Mohammad Jafferany Department of Psychiatry, Central Michigan University/CMU Medical Education Partners, Saginaw, Michigan, USA

Keywords:

Quality of Life, Lichen Planopilaris, frontal fibrosing alopecia, diffuse variant

Abstract

Introduction: Diffuse lichen planopilaris (DLPP) is a rare inflammatory scalp disorder that leads to progressive scarring alopecia, affecting patients' physical and psychological well-being.

Objective:  To assess quality of life (QoL) in Moroccan patients with DLPP and identify factors influencing their well-being.

Materials and Methods: A cross-sectional study included 87 patients with DLPP at Cheikh Khalifa and Mohammed VI International University Hospitals in Casablanca, Morocco. The Dermatology Life Quality Index (DLQI) was used to assess the impact of DLPP on daily activities, emotional health, and social interactions.

Results: The majority of patients were females (75.86%). Hair loss occurred in 90% of cases, with changes in hair quality (85.06%), pruritus (85.06%), and trichodynia (43.7%). Diffuse scales were visible in 87.36% of cases, with erythema present in 55.17%. Localized patches and early frontal fibrosing alopecia coexisted with DLPP in 6.9% and 65.52% of patients, respectively; 40.2% of patients had a DLQI >10, which indicates serious QoL impairment. The ‘symptoms’ domain was most affected, particularly among individuals with trichodynia (P=0.038) and changes in hair quality (P=0.009).

Conclusion: DLPP markedly reduced QoL, especially in symptomatic forms. Trichodynia and decreased hair quality significantly impacted daily functioning and leisure activities. Early diagnosis and management are crucial to preserve hair potential and protect mental health.

References

Rajan A, Rudnicka L, Szepietowski JC, et al. Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review. J Cosmet Dermatol. 2022;21(6):2324‑30. PMID: 34661965 DOI: 10.1111/jocd.14457

Fechine COC, Valente NYS, Romiti R. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features. An Bras Dermatol. 2022;97(3):348‑57. PMCID: PMC9133245 DOI: 10.1016/j.abd.2021.08.008

Armenores P, Shirato K, Reid C, Sidhu S. Frontal fibrosing alopecia associated with generalized hair loss: frontal fibrosing alopecia. Australas J Dermatol. 2010;51(3):183-185. PMID: 20695856 DOI: 10.1111/j.1440-0960.2010.00653.x

Kossard S. Postmenopausal frontal fibrosing alopecia: Scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130:770-774. PMID: 31926219 DOI: 10.1016/j.jaad.2019.12.056

Griggs J, Trüeb RM, Gavazzoni Dias MFR, Hordinsky M, Tosti A. Fibrosing alopecia in a pattern distribution. J Am Acad Dermatol. 2021;85(6):1557‑64.

Starace M, Orlando G, Alessandrini A, Baraldi C, Bruni F, Piraccini BM. Diffuse variants of scalp lichen planopilaris: Clinical, trichoscopic, and histopathologic features of 40 patients. J Am Acad Dermatol. 2020;83(6):1659‑67. PMID: 31706933 DOI: 10.1016/j.jaad.2019.11.006

Kelati A, Jafferany M. Quality-of-life assessment and the impact of early diagnosis and treatment in lichen planopilaris: a systematic review. Clin Exp Dermatol. 2024;50(1):146‑9. PMID: 39152785 DOI: 10.1093/ced/llae339

Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: Efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62(3):387‑92. PMID: 20061052 DOI: 10.1016/j.jaad.2009.08.054

Khoudri I ,Lamchahab FZ ,Rmili M, Ismaili N ,Hassam B ,Abouqal R. Traduction, adaptation transculturelle et validation de la version arabe pour le Maroc du Dermatology Life Quality Index (DLQI). Revue d'épidémiologie et de santé publique . 2009;57:S35. Doi : 10.1016/j.respe.2009.02.122

Nasimi M, Ahangari N, Lajevardi V, Mahmoudi H, Ghodsi SZ, Etesami I. Quality of life and mental health status in patients with lichen planopilaris based on Dermatology Life Quality Index and General Health Questionnaire-28 questionnaires. Int J Womens Dermatol. 2020;6(5):399‑403. PMCID: PMC8060658 DOI: 10.1016/j.ijwd.2020.09.005

Saceda-Corralo D, Pindado-Ortega C, Moreno-Arrones ÓM, et al. Health-Related Quality of Life in Patients With Frontal Fibrosing Alopecia. JAMA Dermatol. 2018;154(4):479. PMCID: PMC5876853 DOI: 10.1001/jamadermatol.2017.6330

Doche I, Romiti R, Rivitti-Machado MC, et al . MK. Quality-of-life impairment is not related to disease activity in lichen planopilaris and frontal fibrosing alopecia. Results of a preliminary cross-sectional study. J Eur Acad Dermatol Venereol. 2022;36(4):e288-e290. PMID: 34753220 DOI: 10.1111/jdv.17798

Chiang YZ, Bundy C, Griffiths CEM, Paus R, Harries MJ. The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia. Br J Dermatol. 2015;172(1):130‑7. PMID: 25039441 DOI: 10.1111/bjd.13259

Varghaei A, Rostami A, Yarmohamadi M, Mahmoudi H, Balighi K, Daneshpazhooh M. Assessment of health‐related quality of life in patients with frontal fibrosing alopecia. J Cosmet Dermatol. 2022;21(11):6169‑73. PMID: 35757901 DOI: 10.1111/jocd.15183

Porriño-Bustamante ML, Montero-Vílchez T, Fernández-Pugnaire MA, Arias-Santiago S. Frontal Fibrosing Alopecia Quality of Life Index: A Validated Disease-Specific Questionnaire Involving Women. J Clin Med. 2023;12(3):824. PMCID: PMC9917648 DOI: 10.3390/jcm12030824

Downloads

Published

2026-01-30

How to Cite

1.
Kelati A, Faik M, Chiheb S, El Jazouli M, Jafferany M. Quality of Life in Patients with Diffuse Lichen Planopilaris: A Cross-Sectional Study of 87 Moroccan Cases. Dermatol Pract Concept. 2026;16(1):5763. doi:10.5826/dpc.1601a5763

Share